Profile image
Story Views

Last Hour:
Last 24 Hours:

Worldwide Cancer Diagnostics Device Market 2016 Trend, Analysis and Overview

Thursday, February 23, 2017 23:53
% of readers think this story is Fact. Add your two cents.

(Before It's News)

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options. 

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

Publisher’s analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

For more information about this report:  

Covered in this report 
The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography: 
- Americas

Publisher’s report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
- Abbott Diagnostics
- Agilent Technologies
- BD
- bioMérieux
- Qiagen
- Roche Diagnostics


Request Sample Copy at


Other prominent vendors 
- Affymetrix 
- Ambry Genetics 
- Annoroad 
- Aviva Biosciences
- Biochain 
- Bio-Rad
- Cancer Genetics
- Cepheid
- CompanionDx 
- DiagnoCure 
- Epic Sciences 
- Epigenomics 
- Genomic Health 
- HalioDX 
- Hologic 
- Illumina
- Myriad Genetics
- Thermo Fisher Scientific 
- Ventana Medical Systems 
- Vysis

Market driver 
- Demand for personalized medicines
- For a full, detailed list, view our report 

Market challenge 
- High cost of developing companion diagnostics
- For a full, detailed list, view our report 

Market trend 
- Demand for personalized medicines 
- For a full, detailed list, view our report 

Inquire for Report at   

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.